Arkolith/Insider Trading/OCUP/Form 4

Manuso James S J

DirectorOcuphire Pharma, Inc. (OCUP) · full profile →Form 4 · filed Oct 12, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 11, 2022Option exercise(X)787—$036K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 11, 2022Option exercise(X)787—$00

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-036952) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML